WHO & Republic of Korea Tie-Up For Biomanufacturing Training
The World Health Organisation as well as the Republic of South Korea have gone ahead...
UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia
UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build...
Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation
Lonza announces the start of new mid-scale manufacturing assets at its API manufacturing center in...
How ‘First-Time Right’ Formulations Can Help Address the Challenge of Affordable Medicines
For years, global healthcare systems have been facing the triple threat of rising incidences of...
By 2030, OSD Contract Manufacturing Will Be $54.7 Billion
The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion...
By 2026, Pharma Contract Manufacturing To Be Worth $130bn
The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as...
Leanings In The Biopharma Contract Manufacturing For 2022
A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of...
FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US...
Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production
COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take,...
RCPE and InSilicoTrials to Digitalize and Accelerate the Development of Pharmaceutical Manufacturing Processes
RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software....